Antiinflammatory lactones

Details for Australian Patent Application No. 2005231939 (hide)

Owner Novartis AG

Inventors Meingassner, Josef Gottfried; Thirring, Klaus

Agent Davies Collison Cave

Pub. Number AU-B-2005231939

PCT Pub. Number WO2005/097771

Priority 0407466.2 01.04.04 GB; 0407467.0 01.04.04 GB

Filing date 31 March 2005

Wipo publication date 20 October 2005

Acceptance publication date 22 May 2008

International Classifications

C07D 309/36 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/097771 Priority application(s): WO2005/097771

22 May 2008 Application Accepted

  Published as AU-B-2005231939

18 September 2008 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005231941-Device for coating both sides of a substrate with a hydrophobic layer

2005231937-Novel diazine derivatives, their manufacture and use as pharmaceutical agents